<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Albasanz-Puig A</submitter><funding>Instituto de Salud Carlos III</funding><pagination>733</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9027680</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(4)</volume><pubmed_abstract>To assess the effect of combination antibiotic empirical therapy on 30-day case-fatality rate in neutropenic cancer patients with &lt;i>Pseudomonas aeruginosa&lt;/i> (PA) bacteremic pneumonia. This was a multinational, retrospective cohort study of neutropenic onco-hematological patients with PA bloodstream infection (BSI) (2006-2018). The effect of appropriate empirical combination therapy, appropriate monotherapy and inappropriate empirical antibiotic therapy [IEAT] on 30-day case-fatality was assessed only in patients with PA bacteremic pneumonia. Among 1017 PA BSI episodes, pneumonia was the source of BSI in 294 (28.9%). Among those, 52 (17.7%) were caused by a multidrug-resistant (MDR) strain and 68 (23.1%) received IEAT, mainly when the infection was caused by an MDR strain [38/52 (73.1%) </pubmed_abstract><journal>Microorganisms</journal><pubmed_title>Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with &lt;i>Pseudomonas aeruginosa&lt;/i> Pneumonia.</pubmed_title><pmcid>PMC9027680</pmcid><funding_grant_id>CB21/13/00009, CB21/13/00079, CB21/13/00054, CB21/13/00086, CB21/13/00012</funding_grant_id><pubmed_authors>Martin-Davila P</pubmed_authors><pubmed_authors>Hemmati P</pubmed_authors><pubmed_authors>Tilley R</pubmed_authors><pubmed_authors>Dura-Miralles X</pubmed_authors><pubmed_authors>Albasanz-Puig A</pubmed_authors><pubmed_authors>Carratala J</pubmed_authors><pubmed_authors>Aguado JM</pubmed_authors><pubmed_authors>Kern WV</pubmed_authors><pubmed_authors>Mussetti A</pubmed_authors><pubmed_authors>Araos R</pubmed_authors><pubmed_authors>Puerta-Alcalde P</pubmed_authors><pubmed_authors>Herrera F</pubmed_authors><pubmed_authors>Novo A</pubmed_authors><pubmed_authors>Ruiz-Camps I</pubmed_authors><pubmed_authors>Gomes MZR</pubmed_authors><pubmed_authors>Montero M</pubmed_authors><pubmed_authors>Drgona L</pubmed_authors><pubmed_authors>Del Pozo JL</pubmed_authors><pubmed_authors>Morales HMP</pubmed_authors><pubmed_authors>Gudiol C</pubmed_authors><pubmed_authors>Laporte-Amargos J</pubmed_authors><pubmed_authors>Mikulska M</pubmed_authors><pubmed_authors>Retamar-Gentil P</pubmed_authors><pubmed_authors>Akova M</pubmed_authors><pubmed_authors>Pallares N</pubmed_authors><pubmed_authors>Manzur A</pubmed_authors><pubmed_authors>Abdala E</pubmed_authors><pubmed_authors>Marin JI</pubmed_authors><pubmed_authors>Calik S</pubmed_authors><pubmed_authors>Peghin M</pubmed_authors><pubmed_authors>Yanez L</pubmed_authors><pubmed_authors>On Behalf Of The Ironic Study Group</pubmed_authors><pubmed_authors>Gasch O</pubmed_authors><pubmed_authors>Sipahi OR</pubmed_authors><pubmed_authors>Bergas A</pubmed_authors><pubmed_authors>Garcia E</pubmed_authors><pubmed_authors>Isler B</pubmed_authors><pubmed_authors>Kanj SS</pubmed_authors><pubmed_authors>Oltolini C</pubmed_authors><pubmed_authors>Montejo JM</pubmed_authors><pubmed_authors>Brunel AS</pubmed_authors><pubmed_authors>Marquez-Gomez I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with &lt;i>Pseudomonas aeruginosa&lt;/i> Pneumonia.</name><description>To assess the effect of combination antibiotic empirical therapy on 30-day case-fatality rate in neutropenic cancer patients with &lt;i>Pseudomonas aeruginosa&lt;/i> (PA) bacteremic pneumonia. This was a multinational, retrospective cohort study of neutropenic onco-hematological patients with PA bloodstream infection (BSI) (2006-2018). The effect of appropriate empirical combination therapy, appropriate monotherapy and inappropriate empirical antibiotic therapy [IEAT] on 30-day case-fatality was assessed only in patients with PA bacteremic pneumonia. Among 1017 PA BSI episodes, pneumonia was the source of BSI in 294 (28.9%). Among those, 52 (17.7%) were caused by a multidrug-resistant (MDR) strain and 68 (23.1%) received IEAT, mainly when the infection was caused by an MDR strain [38/52 (73.1%) </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-05-18T12:07:29.408Z</modification><creation>2025-02-19T03:58:32.589Z</creation></dates><accession>S-EPMC9027680</accession><cross_references><pubmed>35456784</pubmed><doi>10.3390/microorganisms10040733</doi></cross_references></HashMap>